Immunity against cancer: lessons learned from melanoma
- 22 February 2001
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 13 (2) , 134-140
- https://doi.org/10.1016/s0952-7915(00)00195-3
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte–defined Peptide Derived from the Tumor Antigen MAGE-3The Journal of Experimental Medicine, 1999
- Tumor immunity and autoimmunity induced by immunization with homologous DNA.Journal of Clinical Investigation, 1998
- Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 MelanomaThe Journal of Experimental Medicine, 1997
- Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.The Journal of Experimental Medicine, 1996
- Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein.The Journal of Experimental Medicine, 1995
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.The Journal of Experimental Medicine, 1990
- Structure of the gene of tum− transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cellsCell, 1989
- Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.The Journal of Experimental Medicine, 1984
- Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.The Journal of Experimental Medicine, 1982